OKYO Pharma annual return on equity
2021
2022
2023
2026
OKYO Pharma Return on Equity (ROE) Growth & History (OKYO)
OKYO Pharma's return on equity was −263.78% for fiscal 2026.
View full OKYO Pharma company overviewOKYO Pharma annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-03-31 | −263.78% | — |
| 2023 | 2023-03-31 | −2,968.51% | −2837.12 pp |
| 2022 | 2022-03-31 | −131.39% | −1.90 pp |
| 2021 | 2021-03-31 | −129.50% | — |
OKYO Pharma return on equity trends
Over the last five fiscal years, OKYO Pharma's return on equity decreased from −129.50% to −263.78%, a change of −134.29 percentage points.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review OKYO Pharma source filings ↗